Lombard Medical Technologies (LSE:LMT) EV-to-EBITDA : -10.48 (As of Jun. 06, 2024)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lombard Medical Technologies's enterprise value is £84.34 Mil. Lombard Medical Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.05 Mil. Therefore, Lombard Medical Technologies's EV-to-EBITDA for today is -10.48.

The historical rank and industry rank for Lombard Medical Technologies's EV-to-EBITDA or its related term are showing as below:

LSE:LMT's EV-to-EBITDA is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 15.92
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Lombard Medical Technologies's stock price is £1.89. Lombard Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.201. Therefore, Lombard Medical Technologies's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Lombard Medical Technologies EV-to-EBITDA Historical Data

The historical data trend for Lombard Medical Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EV-to-EBITDA Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

EV-to-EBITDA

Get a 7-Day Free Trial

-0.12

-0.89

-3.19

-1.50

-4.39

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EV-to-EBITDA	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Lombard Medical Technologies's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lombard Medical Technologies's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's EV-to-EBITDA falls into.

Lombard Medical Technologies EV-to-EBITDA Calculation

Lombard Medical Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	84.341	/	-8.049
	=	-10.48

Lombard Medical Technologies's current Enterprise Value is £84.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lombard Medical Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.05 Mil.

Lombard Medical Technologies (LSE:LMT) EV-to-EBITDA Explanation

Lombard Medical Technologies's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	1.89	/	-0.201
	=	At Loss

Lombard Medical Technologies's share price for today is £1.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lombard Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.201.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Lombard Medical Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.